Modalis Therapeutics: Meet Yosuke Nakashima from our TechNet Partners

(3:50)

BIG PRICE RECOVERY : MODALIS THERAPEUTICS STOCK ANALYSIS | TYO:4883

(1:55)

DEFACTO FINAL CONFERENCE IV: Modalis Outcomes

(26:29)

Prolonged Sitting Increases Heart Risks, Carbon Nanotubes Transform Composites, JCR and Modalis C...

(10:6)

Andreas Resch, Modalis Management and Partner, Acent

(2:21)

Modalis Infrastructure Partners Inc. - Corporate Video

(2:21)

01 Modalis and Collections

(3:24)

Second Home Spanje | Testimonial Modalis

(4:51)

4DMolecular Therapeutics

(15:1econd)

Sangamo Therapeutics CEO: Alzheimer's and Parkinson's Gene Therapies | Mad Money | CNBC

(6:26)

LIFE SCIENCES | DAILY NEWS | JANUARY 06, 2025 | PHARMASHOTS

(1:6)

LIFE SCIENCES | DAILY NEWS | OCTOBER 28, 2024 | PHARMASHOTS

(1:)

Addressing the Production Needs of Cell and Gene Therapeutics: New Strategies for a Changing World

(59:17)

LogicBio Therapeutics

(12:54)

Gene therapy is the future of medicine - here's how | Dr. Nafiseh Nafissi | TEDxToronto

(10:56)

BioStock Life Science Summit 2021 | Modus Therapeutics

(19:48)

LIFE SCIENCES | DAILY NEWS | MAY 07, 2024 | PHARMASHOTS

(1:2)

Nanopore sequencing and functional screening of AAV genomes for optimal production and function

(15:)

Takeda - Our History

(6:6)

angels

(3:25)

おすすめバイオ株【モダリス】独自の遺伝子治療（4883）

(11:57)